KOSDAQ · Healthcare · ₩705B
₩18,400-3.51%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Short Volume 6.7% · as of 26.10.26
Among 37 신약 개발 peers
Quarterly Revenue Growth
“신약 성과를 기다리며 투자를 이어가는 단계예요.”
In the company's words · 2026 2분기 filing